What's in a TRT Consent Form (and What to Ask Before Signing)

A TRT consent form is meant to document that you understand what the treatment is for, what could go wrong, what monitoring you agree to, and what the clinic expects from you. Most include sections on benefits and risks, fertility, lab follow-up, and the extra rules that come with a controlled substance. The American Medical Association (AMA) says informed consent should cover the diagnosis, the purpose of the treatment, the burdens, risks and expected benefits of all options including declining treatment, and that you have the right to ask questions. Read the form before you pay or sign.

Forms differ by clinic, so what follows describes common sections rather than any one document. Informed consent is supposed to be a conversation, with the signature as the record of it. If you only receive a checkbox and no chance to ask questions, treat that as a warning sign. See our TRT clinic red flags for others.

What the form is for

AMA Opinion 2.1.1 says physicians should present information accurately and sensitively, assess whether the patient can understand it and decide voluntarily, and document the consent conversation and the decision in the medical record. When written consent is given, the form belongs in the record. A related opinion says a patient with decision-making capacity has the right to decline or halt any medical intervention. A signature is evidence that the conversation happened; it does not replace asking questions.

Diagnosis and expected benefits

You should see a statement that you have been evaluated and that treatment is recommended for a specific condition, usually hypogonadism. FDA labels describe testosterone replacement for adult men with low or absent testosterone linked to specific conditions, and the Depo-Testosterone label says to confirm hypogonadism with morning testosterone on at least two separate days. Check that the form matches your records. Our guide to the labs telehealth providers require shows what a thorough workup looks like.

Expected benefits, without guarantees

Good forms describe potential benefits with language like "may" and "some patients." A form that promises specific outcomes or timelines is overselling. Benefits vary, and not everyone responds.

Risks you should see, and where they come from

FDA labels for testosterone products list these items. A good consent form covers them in plain language:

• Red blood cell count. Polycythemia is a labeled warning. The Testim label calls for a hematocrit check before starting, at 3 to 6 months, then yearly. See hematocrit on TRT.
• Blood clots. Labels report postmarketing cases of deep vein thrombosis and pulmonary embolism. The Testim label also notes that in TRAVERSE venous thromboembolism occurred at a numerically higher rate than placebo (1.7 percent versus 1.2 percent).
• Blood pressure. The FDA asked in February 2025 for increased-blood-pressure warnings across testosterone products, and labels say not to use them with uncontrolled hypertension.
• Prostate. Labels list breast cancer and known or suspected prostate cancer as contraindications, and call for prostate evaluation before and during treatment. They also warn that BPH symptoms can worsen. In June 2026 HHS announced requested label changes to this language, so ask which version your clinic is working from.
• Sleep apnea, gynecomastia, edema and lipids. Labels say testosterone may worsen sleep apnea, that breast enlargement may develop and persist, that fluid retention can be serious in heart, kidney or liver disease, and that lipid profiles can change.
• Mood. The Jatenzo label notes depression and suicidal ideation reported in trials and tells patients to seek care for new or worsening mood changes.
• Skin transfer for gels. The Testim label carries a boxed warning: children exposed to gel from men using it have developed virilization, so children and women should avoid contact with unwashed or unclothed application sites.
• Compounded preparations. The AUA guideline says commercially manufactured products should be prescribed rather than compounded testosterone when possible.

Ask which items the prescriber considers most relevant to you. For the big picture on heart safety, see the TRAVERSE explainer.

Fertility and family planning

A responsible form says testosterone can suppress sperm production. The Testim label states that large doses may suppress spermatogenesis and that the impact on fertility may be irreversible. The AUA guideline says exogenous testosterone should not be prescribed to men who are currently trying to conceive and that the long-term effect on sperm production should be discussed; the Endocrine Society likewise advises against starting treatment in men planning fertility in the near term. If you want children now or later, discuss alternatives before signing. Our pieces on sperm preservation and fertility-preserving alternatives explain the options.

Monitoring you are agreeing to

Most agreements require follow-up lab tests and visits, and may state that refills depend on completing them. The Endocrine Society calls for a standardized plan that includes measuring testosterone and hematocrit and evaluating prostate cancer risk in the first year, and the AUA suggests rechecking testosterone every 6 to 12 months. Look for:

• What labs are required and how often.
• Who orders them, where you go, and who pays.
• What happens if results are out of range, for example a pause in treatment or a review by the clinician.
• How blood pressure, prostate and sleep symptoms are handled.

The monitoring requirement protects you. A program with no follow-up plan is a bigger concern than one that is strict about labs.

Controlled-substance terms

Testosterone is a Schedule III controlled substance. Under 21 CFR 1306.22, a Schedule III prescription cannot be filled or refilled more than six months after it was issued or refilled more than five times, so expect periodic new prescriptions. Beyond that federal baseline, clinic agreements often add their own policies, such as using one pharmacy, not sharing or selling medication, secure storage, or consequences for violating the terms. Those come from clinic policy rather than from FDA labeling, so ask which apply and what could end your treatment. Telehealth prescribing rules for controlled substances have also been changing, so ask how that affects your refills.

Telehealth, money and privacy

If your care is remote, the form may cover identity verification, the state you must be located in during visits, limits of care without a physical exam and what to do in an emergency. Our walkthrough of the first telehealth visit shows what to expect.

Money, privacy and leaving

Some agreements bundle financial terms. Check recurring charges, renewal dates, refund and cancellation rules, and what is included versus billed separately. Confirm how your data is stored and shared, and how you can obtain your records if you leave. See how to switch clinics for what to request on the way out.

Red flags in a consent form

• No mention of risks, or only a vague "side effects may occur."
• No discussion of fertility when sperm suppression is a labeled effect.
• Promises of specific results or timelines.
• No monitoring requirement, or monitoring that exists only to sell add-ons.
• Pressure to sign immediately or to pay before you have seen the document.
• Waivers that claim to remove your right to complain to a licensing board or seek care elsewhere.
• No way to reach a clinician with questions.

One flag on its own may reflect a sloppy template; several together suggest finding another provider.

Questions to ask before you sign

• "Can I take the form home and read it before signing?"
• "What are the risks that matter most for someone with my history?"
• "What happens to my treatment if a lab result is out of range?"
• "What are the exact terms that could cause the clinic to stop prescribing?"
• "How do I get my records and prescription transferred if I leave?"
• "Can I talk to a clinician, not just an administrator, before I agree?"

Frequently Asked Questions

Is a TRT consent form legally binding?

A consent form documents that you were informed and agreed to treatment, but it does not waive your rights as a patient, and legal effect varies by state and document. If you have concerns, a licensed attorney can advise.

Can I refuse to sign part of the consent form?

You can ask questions and request clarification or changes, but clinics may require certain terms to prescribe. If you are uncomfortable, you can decline and seek care elsewhere.

Why does a TRT consent form mention controlled substances?

In the United States testosterone is a Schedule III controlled substance, so prescribing comes with additional rules, such as limits on refills under federal regulation, that clinics often write into their agreements.

What if the form promises results?

Treat guaranteed outcomes as a red flag. Responsible forms describe possible benefits and risks without guarantees.

Can I get a copy of what I signed?

You should be able to. Ask for a copy of the consent and any treatment agreement for your records, and keep it with your other TRT paperwork.

The Bottom Line

Sources and Verification Note